Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral tablet, ASC30, in obese individuals.

Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib Tablets.

The global pharmaceutical tablet packaging equipment market is expected to grow at a CAGR of almost 9% during the forecast period, 2017-2021.

Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black ...

Cingulate has posted pharma | Cingulate has posted pharmacokinetic data from an early-phase clinical trial of its triple-release anxiety drug candidate, providing itself with a platform to support ...

District consumer forum-I, UT, has directed a Baddi-based pharmaceutical company Cap-Tap biotech to pay Rs 2,000 for negligence for staple pin found embedded in a tablet manufactured by it.

Hyderabad News:Natco Pharma launches anticoagulant tabletDrugmaker Natco Pharma on Thursday said that it has launched an anti-blood clot tablet, Rivaroxaban, in the country.

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension and Quillivant ER Chewable Tablet for the Treatment of Attention Deficit Hyperactivity Disorder ...

JAMP Pharma Corporation is recalling two doses of its digoxin tablets because some bottles may contain an incorrect dose, Health Canada announced.

Hyderabad (Telangana) [India], September 9 (ANI): Hyderabad-based Zenara Pharma, has announced that it has launched Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for ...

Aurobindo Pharma gains FDA approval to manufacture and market Rivaroxaban Tablets USP, with plans to launch by June.